http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_909bae5d713f7ede00658cbd013d082e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sznol |
| name | Mario Sznol |
| given-name | Mario |
| organization-name | From the Frederick Cancer Research and Development Center, Biological Response Modifiers Program, National Cancer Institute, and Clinical Services Program, SAIC Frederick, NCI-FCRDC, both of Frederick, MD; the Biometric Research Branch and the Investigational Drug Branch, both of the Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and the Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR. Yale University School of Medicine, New Haven, CT Sandra P. D’Angelo, Alexander N. Shoushtari, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; James Larkin, Royal Marsden Hospital, London; Paul Lorigan, University of Manchester, Manchester, United Kingdom; Jeffrey A. Sosman, Vanderbilt University Medical Center, Nashville, TN; Celeste Lebbé, Saint-Louis Hospital, Institut National de la Santé et de la Recherche Médicale U976, Université Paris Diderot, Paris; Julie Charles, Grenoble University... Authors' Affiliation: Yale Cancer Center, New Haven, Connecticut Yale Cancer Center, Yale School of Medicine, New Haven, CT 1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. James Larkin, Royal Marsden NHS Foundation Trust, London; Paul Lorigan, The Christie National Health Service Foundation Trust, Manchester, United Kingdom; David Minor, California Pacific Medical Center Research Institute; Adil Daud, University of California San Francisco, San Francisco; Bartosz Chmielowski, University of California, Santa Monica, CA; Sandra D'Angelo, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; Jeffrey Weber, Perlmutter Cancer Center at New York... 10Yale Cancer Center, Yale School of Medicine, Yale, Connecticut. Yale Cancer Center, Yale University School of Medicine, New Haven, CT 2Smilow Cancer Center, Yale University School of Medicine, New Haven, Connecticut. Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut 4Vion Pharmaceuticals, Inc., New Haven, Connecticut Margaret K. Callahan, Michael A. Postow, Neil H. Segal, Alexander Lesokhin, and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY; Harriet Kluger and Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, and Yale-New Haven Hospital, New Haven, CT; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA; and Suba Krishnan, Rafia... Medical Oncology, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, Connecticut Yale School of Medicine, New Haven, CT Scott N. Gettinger and Mario Sznol, Yale Cancer Center, New Haven, CT; Leora Horn, David P. Carbone, and Jeffrey A. Sosman, Vanderbilt University Medical Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Leena Gandhi, David M. Jackman, and F. Stephen Hodi, Dana-Farber Cancer Institute; Rebecca S. Heist and Lecia V. Sequist, Massachusetts General Hospital Cancer Center; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Scott J. Antonia and Mary... 16Yale Comprehensive Cancer Center, New Haven, Connecticut. 1Medicine and Departments of Authors' Affiliations: 1Yale Cancer Center and 2Department of Pathology, Yale University School of Medicine, New Haven, Connecticut; and 3VA Connecticut Healthcare System, VA Cancer Center, West Haven, Connecticut From the Surgery Branch, Center for Cancer Research, National Cancer Institute; Clinical Pathology Department, Microbiology Service, National Institutes of Health, Bethesda, MD; and Vion Pharmaceuticals, New Haven, CT. Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut 2Vion Pharmaceuticals, Inc., New Haven, Connecticut From the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) — both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) — all in Italy; Division of Medical Oncology, University... Authors' Affiliations: 1Yale Cancer Center; Departments of 2Dermatology, 3Radiology, 4Pathology, and 5Surgery, Yale University School of Medicine; and 6Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut Yale School of Medicine, New Haven, Connecticut. Yale Cancer Center, New Haven, Connecticut. Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA 1Yale University School of Medicine, New Haven, Connecticut. 2Yale School of Medicine, New Haven, Connecticut. 5Yale Cancer Center, New Haven, Connecticut. Comprehensive Cancer Center Section of Medical Oncology, Yale University School of Medicine, New Haven, CT, USA Section of Medical Oncology, Department of Internal Medicine, Yale University, New Haven, CT David F. McDermott, Beth Israel Deaconess Medical Center; Toni K. Choueiri, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Igor Puzanov and F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Charles G. Drake, Julie R. Brahmer, Hans J. Hammers, Suzanne L. Topalian, and Drew M. Pardoll, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale–New Haven Hospital, New Haven, CT; John D. Powderly... Yale University, New Haven, Connecticut 4Section of Medical Oncology, Department of Internal Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut. From the Cytokine Working Group and Surgery Branch, National Cancer Institute, Bethesda, MD; Modified Group C Program; and Chiron Corp, Emeryville, CA. 1Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut. From the Divisions of Hematology and Oncology and Surgical Oncology, Human Cancer Genetics, and Center for Biostatistics, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH; and Yale University, New Haven, CT 1Medicine, Departments of John Heymach, Maura L. Gillison, and Shannon Neville Westin, The University of Texas MD Anderson Cancer Center, Houston, TX; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Anthony Alberg, Medical University of South Carolina, Charleston, SC; Nancy Baxter, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada; Susan Marina Chang and Andrew H. Ko, University of... Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT Suzanne L. Topalian, William H. Sharfman, Julie R. Brahmer, Evan J. Lipson, Janis M. Taube, and Drew M. Pardoll, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Mario Sznol and Harriet M. Kluger, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; David F. McDermott, Beth Israel Deaconess Medical Center; Donald P. Lawrence, Massachusetts General Hospital Cancer Center; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston,... Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY; Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA; Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT; Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX; Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ. Authors' Affiliation: Department of Medicine and Immunobiology, Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut 6Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut. 17Yale School of Medicine, New Haven, Connecticut. 3Vion Pharmaceuticals, Inc., New Haven, Connecticut Yale University School of Medicine and Yale Cancer Center, New Haven, CT Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F... 3Yale University School of Medicine, New Haven, Connecticut. Yale Cancer Center Yale University New Haven Connecticut USA; Department of Medicine Yale University School of Medicine New Haven Connecticut USA Department of Internal Medicine, Section of Medical Oncology;; Yale Cancer Center, New Haven, Connecticut Surgery Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Suzanne L. Topalian, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Hewei Li, Ian M. Waxman, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ; Dirk Schadendorf, University of... 11Yale University, New Haven, Connecticut. 4Yale University Cancer Center, Yale University, New Haven, Connecticut. *Department of Medicine, Yale University School of Medicine, New Haven, CT 06520;; †Smilow Cancer Center, Yale University School of Medicine, New Haven, CT 06520; 2Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. From the Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York (J.D.W., M.K.C., M.A.P., N.A.R., A.M.L., N.H.S., C.E.A., R.-A.G., S.A.K., B.U.A.); Yale University School of Medicine and Smilow Cancer Center, Yale–New Haven Hospital, New Haven, CT (H.K., K.R., M.M.B., A.C., M.S.); Dako North America, Carpinteria (X.Z.), and Bristol-Myers Squibb, Redwood City (A.J.K.) — both in California; and Bristol-Myers Squibb, Princeton, NJ (I.L., H.D.I., W.F., C.E.H., Q.H., J.M.W., A.G.). Medical Oncology, Yale University School of Medicine, New Haven, Connecticut. Professor, Internal Medicine, Leader, Melanoma/Renal Cell Disease Research Team, Associate Chief, Section of Medical Oncology, Yale University, New Haven, CT David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Jeffrey A. Sosman, Vanderbilt University School of Medicine; Jeffrey R. Infante, Sarah Cannon Research Institute, Nashville, TN; Mario Sznol, Yale Cancer Center, New Haven, CT; Christophe Massard, Gustave Roussy, Villejuif Cedex, France; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Omid Hamid, Angeles Clinic and Research Institute, Santa Monica; Marcella Fassò, Yan V. Wang, Wei Zou, Priti S. Hedge, and Gregg D. Fine... Yale Cancer Center Yale University New Haven CT USA Georgina V. Long, University of Sydney, and Royal North Shore Hospital; Richard Kefford, Macquarie University, Sydney, and Westmead Hospital, Westmead, New South Wales; Jonathan Cebon, Ludwig Institute for Cancer Research, Melbourne, Victoria, Australia; Zeynep Eroglu, Moffitt Cancer Center, Tampa, FL; Jeffrey Infante, Tennessee Oncology; Douglas B. Johnson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Sapna Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Adil Daud, University... From the Albert Einstein College of Medicine and the Albert Einstein Comprehensive Cancer Center, Bronx, NY; and Vion Pharmaceuticals, Inc, New Haven, CT. Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT; Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan; Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy; David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Pascal Wolter, University Hospitals Leuven, Leuven, Belgium; Celeste Lebbé, Université Paris Diderot, Paris; Luc Thomas, Centre... From the Frederick Cancer Research and Development Center, Biological Response Modifiers Program, National Cancer Institute, Frederick, MD; the Biometric Research Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; the Clinical Services Program, SAIC Frederick, Frederick, MD; Immunex Research and Development Corp, Seattle, WA. Yale Cancer Center, New Haven, CT 06520, USA. Department of Medicine, Yale University, New Haven, CT 06520 |
Incoming Links
Total number of triples: 247.